Ceftazidime-avibactam induced renal disorders: past and present

Ceftazidime-avibactam induced renal disorders: past and present

With the increasing prevalence of multidrug-resistant Gram-negative bacterial pathogens worldwide, antimicrobial resistance has become a significant public health concern. Ceftazidime-avibactam (CAZ-AVI) exhibited excellent in vitro activity against many carbapenemase-producing pathogens, and was wi...

Full description

Bibliographic Details
Main Authors: Yanrong Shi, Jichao Wu, Wei Mi, Xusheng Zhang, Xiuli Ren, Chengwu Shen, Cuicui Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
ceftazidime-avibactam
acute kidney injury
clinical trials
real-world studies
pharmacokinetic/pharmacodynamic
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1329307/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1329307/full

Similar Items